GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tian An Medicare Ltd (HKSE:00383) » Definitions » Cash Flow from Financing

Tian An Medicare (HKSE:00383) Cash Flow from Financing : HK$101 Mil (TTM As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is Tian An Medicare Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Tian An Medicare paid HK$0 Mil more to buy back shares than it received from issuing new shares. It spent HK$10 Mil paying down its debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It spent HK$48 Mil on other financial activities. In all, Tian An Medicare spent HK$58 Mil on financial activities for the six months ended in Dec. 2023.


Tian An Medicare Cash Flow from Financing Historical Data

The historical data trend for Tian An Medicare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tian An Medicare Cash Flow from Financing Chart

Tian An Medicare Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.48 109.49 -79.15 29.90 100.57

Tian An Medicare Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.02 25.96 3.94 162.63 -62.06

Tian An Medicare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Tian An Medicare's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Tian An Medicare's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tian An Medicare  (HKSE:00383) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Tian An Medicare's issuance of stock for the six months ended in Dec. 2023 was HK$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Tian An Medicare's repurchase of stock for the six months ended in Dec. 2023 was HK$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Tian An Medicare's net issuance of debt for the six months ended in Dec. 2023 was HK$-10 Mil. Tian An Medicare spent HK$10 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Tian An Medicare's net issuance of preferred for the six months ended in Dec. 2023 was HK$0 Mil. Tian An Medicare paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Tian An Medicare's cash flow for dividends for the six months ended in Dec. 2023 was HK$0 Mil. Tian An Medicare received HK$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Tian An Medicare's other financing for the six months ended in Dec. 2023 was HK$-48 Mil. Tian An Medicare spent HK$48 Mil on other financial activities.


Tian An Medicare Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Tian An Medicare's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Tian An Medicare (HKSE:00383) Business Description

Traded in Other Exchanges
Address
333 Lockhart Road, 47th Floor, United Asia Finance Centre, Wanchai, Hong Kong, HKG
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services, and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from the Healthcare segment that is engaged in the operations of hospitals in the PRC.

Tian An Medicare (HKSE:00383) Headlines

No Headlines